Join us as we delve into a systematic review from the Department of Dental Medicine at Victor Babes University in Romania on the efficacy and safety of Botulinum toxin Type A (BoNT-A) for treating temporomandibular joint symptoms associated with sleep bruxism. Analyzing nine clinical trials with 137 participants, researchers found significant benefits in pain reduction, jaw function improvement, and decreased bruxism episodes. Despite mild and transient adverse effects, BoNT-A shows promising potential in managing these disorders.

Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:

🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights

👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!

#AIAutomationMinute #DrTeriFisher #HealthcareAI